Expert NetworkExpert InterviewVALN

Slingshot members are talking to an expert! The topic is:

Examining the potential of Valneva and Pfizer's Lyme disease vaccine, VLA15

Executed on:Nov 1, 2022 1:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Mass General Brigham
  • Infectious disease specialist at Mass General Brigham; Trained at Beth Israel Hospital, Brigham & Women's Hospital, Dana-Farber Cancer Institute, Children's Hospital and the Veterans Administration Hospitals.
  • Manages 50 patients with lyme disease. 
  • Specializes in travel medicine, flu, hospital acquired infections, Covid-19, and pneumonia.

Interview Goal

This conversation will focus on VLA15; a multivalent recombinant protein vaccine candidate that targets six serotypes of Borrelia currently in development by Valneva and Pfizer.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.